ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: For instance, chronic myeloid leukemia (CML) is characterized by the expression of a chimeric BCR-ABL oncoprotein in hematopoietic precursor cells [6] which behaves as a potent inhibitor of apoptosis [7].